Daniel W. Lee

11.1k total citations · 3 hit papers
60 papers, 4.7k citations indexed

About

Daniel W. Lee is a scholar working on Oncology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Daniel W. Lee has authored 60 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 13 papers in Molecular Biology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Daniel W. Lee's work include CAR-T cell therapy research (42 papers), Acute Lymphoblastic Leukemia research (12 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Daniel W. Lee is often cited by papers focused on CAR-T cell therapy research (42 papers), Acute Lymphoblastic Leukemia research (12 papers) and Viral Infectious Diseases and Gene Expression in Insects (8 papers). Daniel W. Lee collaborates with scholars based in United States, France and Malaysia. Daniel W. Lee's co-authors include Crystal L. Mackall, Stephan A. Grupp, Michael C. Jensen, Chrystal U. Louis, David Porter, Rebecca Gardner, Nabil Ahmed, Crystal L. Mackall, Nirali N. Shah and Terry J. Fry and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Daniel W. Lee

58 papers receiving 4.6k citations

Hit Papers

Current concepts in the diagnosis and management of cytok... 2012 2026 2016 2021 2014 2012 2021 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Current concepts in the diagnosis and management of cytokine release syndrome
    2014 1.9k citations Daniel W. Lee, Crystal L. Mackall et al. Blood profile →
  2. Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
    2012 440 citations Daniel W. Lee, Nirali N. Shah et al. Blood profile →
  3. Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL
    2021 200 citations Nirali N. Shah, Daniel W. Lee et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel W. Lee United States 26 3.4k 1.0k 971 937 933 60 4.7k
Chrystal U. Louis United States 20 3.5k 1.0× 1.1k 1.1× 1.1k 1.1× 1.3k 1.4× 801 0.9× 56 4.6k
Jennifer N. Brudno United States 19 2.9k 0.9× 1.0k 1.0× 730 0.8× 928 1.0× 877 0.9× 28 3.5k
Nirav N. Shah United States 28 1.7k 0.5× 823 0.8× 390 0.4× 615 0.7× 470 0.5× 207 3.1k
Joseph P. McGuirk United States 30 1.7k 0.5× 1.1k 1.1× 298 0.3× 728 0.8× 247 0.3× 274 3.7k
Susanna Harju-Baker United States 13 1.6k 0.5× 432 0.4× 420 0.4× 398 0.4× 525 0.6× 19 2.1k
Shaun O’Brien United States 22 2.6k 0.8× 1.5k 1.4× 399 0.4× 2.1k 2.3× 472 0.5× 44 4.9k
Judith Feucht Germany 17 1.2k 0.4× 719 0.7× 304 0.3× 820 0.9× 333 0.4× 39 2.4k
Keisuke Watanabe Japan 22 1.1k 0.3× 607 0.6× 445 0.5× 453 0.5× 298 0.3× 125 2.2k
Bhagirathbhai Dholaria United States 24 1.6k 0.5× 718 0.7× 144 0.1× 728 0.8× 219 0.2× 139 2.5k
Djordje Atanackovic Germany 43 2.1k 0.6× 1.6k 1.6× 242 0.2× 2.1k 2.2× 240 0.3× 142 4.4k

Countries citing papers authored by Daniel W. Lee

Since Specialization
Citations

This map shows the geographic impact of Daniel W. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel W. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel W. Lee more than expected).

Fields of papers citing papers by Daniel W. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel W. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel W. Lee. The network helps show where Daniel W. Lee may publish in the future.

Co-authorship network of co-authors of Daniel W. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel W. Lee. A scholar is included among the top collaborators of Daniel W. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel W. Lee. Daniel W. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cobb, Dustin, et al.. (2025). Acquired CAR-T Therapy Resistance in a Pre-Clinical Model of Pediatric Rhabdomyosarcoma Minimal Residual Disease. Transplantation and Cellular Therapy. 31(2). S199–S199.
2.
Yankelevich, Maxim, Archana Thakur, Shakeel Modak, et al.. (2024). Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for ImmunoTherapy of Cancer. 12(3). e008744–e008744. 12 indexed citations
3.
Silbert, Sara, Sanna Madan, Seth M. Steinberg, et al.. (2023). A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trials. Blood Advances. 7(18). 5566–5578. 2 indexed citations
4.
Ligon, John A., Seth M. Steinberg, Toni Foley, et al.. (2022). The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes. Blood Advances. 6(23). 6040–6050. 25 indexed citations
5.
Wayne, Alan S., Van Huynh, Nobuko Hijiya, et al.. (2022). Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia. Haematologica. 108(3). 747–760. 26 indexed citations
6.
Mikkilineni, Lekha, Bonnie Yates, Seth M. Steinberg, et al.. (2021). Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days. Blood Advances. 5(23). 5312–5322. 47 indexed citations
7.
Molina, John C., Seth M. Steinberg, Bonnie Yates, et al.. (2021). Factors Impacting Overall and Event-Free Survival following Post-Chimeric Antigen Receptor T Cell Consolidative Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 28(1). 31.e1–31.e9. 12 indexed citations
8.
Yates, Bonnie, Alexander Ling, Constance M. Yuan, et al.. (2021). Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy. Blood Advances. 6(7). 2167–2182. 35 indexed citations
9.
Shah, Nirali N., Daniel W. Lee, Bonnie Yates, et al.. (2021). Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL. Journal of Clinical Oncology. 39(15). 1650–1659. 200 indexed citations breakdown →
10.
Majzner, Robbie G., Skyler P. Rietberg, Louai Labanieh, et al.. (2018). Low CD19 Antigen Density Diminishes Efficacy of CD19 CAR T Cells and Can be Overcome By Rational Redesign of CAR Signaling Domains. Blood. 132(Supplement 1). 963–963. 7 indexed citations
11.
Nellan, Anandani, Christopher Rota, Robbie G. Majzner, et al.. (2018). Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells. Journal for ImmunoTherapy of Cancer. 6(1). 30–30. 102 indexed citations
12.
Stroncek, David F., Daniel W. Lee, Jiaqiang Ren, et al.. (2017). Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells. Journal of Translational Medicine. 15(1). 59–59. 55 indexed citations
13.
14.
Nellan, Anandani & Daniel W. Lee. (2015). Paving the road ahead for CD19 CAR T-cell therapy. Current Opinion in Hematology. 22(6). 516–520. 12 indexed citations
15.
Tumaini, Barbara, Daniel W. Lee, Luciano Castiello, et al.. (2013). Simplified process for the production of anti–CD19-CAR–engineered T cells. Cytotherapy. 15(11). 1406–1415. 87 indexed citations
16.
Lee, Daniel W., Mandy J. Binning, Victoria K. Shanmugam, et al.. (2011). Muslin-induced intracranial vasculopathic stenosis: A report of two cases. Clinical Neurology and Neurosurgery. 114(1). 63–67. 9 indexed citations
17.
Saluja, Sanjay, et al.. (1999). Embolotherapy of Pulmonary Arteriovenous Malformations with Detachable Balloons: Long-term Durability and Efficacy. Journal of Vascular and Interventional Radiology. 10(7). 883–889. 53 indexed citations
18.
Lee, Daniel W., Robert I. White, T K Egglin, et al.. (1997). Embolotherapy of Large Pulmonary Arteriovenous Malformations: Long-Term Results. The Annals of Thoracic Surgery. 64(4). 930–940. 220 indexed citations
19.
20.
Lee, Daniel W., Robert M. Shelden, & LEO E. REICHERT. (1990). Identification of low and high molecular weight follicle-stimulating hormone receptor-binding inhibitors in human follicular fluid. Fertility and Sterility. 53(5). 830–835. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chrystal U. Louis Breakdown of academic impact, for papers by Jennifer N. Brudno Breakdown of academic impact, for papers by Nirav N. Shah Breakdown of academic impact, for papers by Joseph P. McGuirk Breakdown of academic impact, for papers by Susanna Harju-Baker Breakdown of academic impact, for papers by Shaun O’Brien Breakdown of academic impact, for papers by Judith Feucht Breakdown of academic impact, for papers by Keisuke Watanabe Breakdown of academic impact, for papers by Bhagirathbhai Dholaria Breakdown of academic impact, for papers by Djordje Atanackovic
Rankless by CCL
2026